DexCom down 10% on Medicare coverage for Abbott's FreeStyle Libre CGM

|About: Abbott Laboratories (ABT)|By:, SA News Editor

DexCom (DXCM -10.3%) is under pressure on 50% higher volume in apparent response to Abbott's (ABT +0.5%) announcement that its continuous glucose monitoring (CGM) system, FreeStyle Libre, now has Medicare coverage.

Abbott says the device is calibrated at the factory so no user calibration is necessary and there is no need for routine fingersticks. DexCom's G5 requires both.

Subscribe for full text news in your inbox